RNF168 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.290400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.411400E-01
Normal-vs-Stage2
7.551200E-01
Normal-vs-Stage3
1.581600E-01
Normal-vs-Stage4
1.709830E-01
Stage1-vs-Stage2
8.445600E-01
Stage1-vs-Stage3
4.225500E-02
Stage1-vs-Stage4
6.181700E-02
Stage2-vs-Stage3
7.326100E-02
Stage2-vs-Stage4
5.655300E-03
Stage3-vs-Stage4
6.204500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.513800E-01
Normal-vs-AfricanAmerican
5.312200E-01
Normal-vs-Asian
7.623000E-01
Caucasian-vs-AfricanAmerican
3.042600E-01
Caucasian-vs-Asian
3.485200E-01
AfricanAmerican-vs-Asian
1.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.351200E-01
Normal-vs-Female
8.306800E-01
Male-vs-Female
9.796400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.635200E-01
Normal-vs-Age(41-60Yrs)
5.135800E-01
Normal-vs-Age(61-80Yrs)
9.747400E-01
Normal-vs-Age(81-100Yrs)
5.612200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.866800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.384800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.713200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.403850E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.197900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.422400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.567400E-01
Normal-vs-Daily Drinker
6.449400E-01
Normal-vs-Weekly Drinker
8.665400E-01
Normal-vs-Occasional Drinker
5.174600E-01
Normal-vs-Social Drinker
7.465600E-01
Non Drinker-vs-Daily Drinker
3.650200E-01
Non Drinker-vs-Weekly Drinker
8.183400E-01
Non Drinker-vs-Occasional Drinker
1.253800E-01
Non Drinker-vs-Social Drinker
4.340800E-01
Daily Drinker-vs-Weekly Drinker
5.976600E-01
Daily Drinker-vs-Occasional Drinker
3.283900E-02
Daily Drinker-vs-Social Drinker
1.543170E-01
Weekly Drinker-vs-Occasional Drinker
1.406640E-01
Weekly Drinker-vs-Social Drinker
4.048200E-01
Occasional Drinker-vs-Social Drinker
4.190800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.328600E-01
Normal-vs-Grade 2
6.743700E-02
Normal-vs-Grade 3
4.151700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.168210E-02
Grade 1-vs-Grade 3
6.575100E-03
Grade 1-vs-Grade 4
3.328600E-01
Grade 2-vs-Grade 3
5.481600E-01
Grade 2-vs-Grade 4
6.743700E-02
Grade 3-vs-Grade 4
4.151700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.166800E-01
Normal-vs-NonDiabetic
9.629800E-01
Diabetic-vs-NonDiabetic
8.421000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.454800E-01
Normal-vs-NoPancreatitis
9.089600E-01
Pancreatitis-vs-NoPancreatitis
7.929200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.623800E-01
Normal-vs-N1
7.174800E-01
N0-vs-N1
1.600010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.338600E-01
Normal-vs-TP53-NonMutant
8.041000E-01
TP53-Mutant-vs-TP53-NonMutant
4.354300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
